VEITINGER KLAUS R DR
Insider CIK 1283972 · ICPT Director · RLYP Director · TCDA Director · SCPH Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SCPH scPharmaceuticals Inc. | D To issuer deriv | 2025-10-07 | 2025-10-07 | 6,124 | — | $0 | 0 | SEC↗ |
| SCPH scPharmaceuticals Inc. | D To issuer deriv | 2025-10-07 | 2025-10-07 | 30,000 | — | $0 | 0 | SEC↗ |
| SCPH scPharmaceuticals Inc. | D To issuer deriv | 2025-10-07 | 2025-10-07 | 19,750 | — | $0 | 0 | SEC↗ |
| SCPH scPharmaceuticals Inc. | D To issuer deriv | 2025-10-07 | 2025-10-07 | 16,300 | — | $0 | 0 | SEC↗ |
| SCPH scPharmaceuticals Inc. | A Award deriv | 2025-06-03 | 2025-06-05 | 30,000 | — | $0 | 30,000 | SEC↗ |
| SCPH scPharmaceuticals Inc. | A Award deriv | 2024-06-11 | 2024-06-13 | 19,750 | — | $0 | 19,750 | SEC↗ |
| SCPH scPharmaceuticals Inc. | A Award deriv | 2023-06-06 | 2023-06-08 | 17,300 | — | $0 | 17,300 | SEC↗ |
| TCDA Tricida, Inc. | A Award deriv | 2022-06-15 | 2022-06-16 | 27,207 | — | $0 | 27,207 | SEC↗ |
| SCPH scPharmaceuticals Inc. | A Award deriv | 2022-06-14 | 2022-06-15 | 16,300 | — | $0 | 16,300 | SEC↗ |
| TCDA Tricida, Inc. | A Award deriv | 2021-06-10 | 2021-06-11 | 57,235 | — | $0 | 57,235 | SEC↗ |
| TCDA Tricida, Inc. | A Award | 2021-06-10 | 2021-06-11 | 16,403 | — | $0 | 27,584 | SEC↗ |
| SCPH scPharmaceuticals Inc. | A Award deriv | 2021-06-08 | 2021-06-10 | 16,300 | — | $0 | 16,300 | SEC↗ |
| TCDA Tricida, Inc. | A Award deriv | 2020-06-11 | 2020-06-15 | 22,967 | — | $0 | 22,967 | SEC↗ |
| TCDA Tricida, Inc. | A Award | 2020-06-11 | 2020-06-15 | 5,670 | — | $0 | 46,985 | SEC↗ |
| SCPH scPharmaceuticals Inc. | A Award deriv | 2020-06-09 | 2020-06-11 | 6,124 | — | $0 | 6,124 | SEC↗ |
| TCDA Tricida, Inc. | M Exercise deriv | 2019-11-01 | 2019-11-05 | 1,750 | — | $0 | 0 | SEC↗ |
| TCDA Tricida, Inc. | S Sale | 2019-11-01 | 2019-11-05 | 1,750 | $38.87 | $68.0K | 51,444 | SEC↗ |
| TCDA Tricida, Inc. | M Exercise | 2019-11-01 | 2019-11-05 | 1,750 | $0.80 | $1.4K | 43,065 | SEC↗ |
| TCDA Tricida, Inc. | S Sale | 2019-11-01 | 2019-11-05 | 1,750 | $38.88 | $68.0K | 41,315 | SEC↗ |
| TCDA Tricida, Inc. | S Sale | 2019-11-01 | 2019-11-05 | 1,750 | $38.88 | $68.0K | 51,444 | SEC↗ |
| TCDA Tricida, Inc. | M Exercise deriv | 2019-10-25 | 2019-10-29 | 1,750 | — | $0 | 1,750 | SEC↗ |
| TCDA Tricida, Inc. | S Sale | 2019-10-25 | 2019-10-29 | 1,750 | $36.31 | $63.5K | 41,315 | SEC↗ |
| TCDA Tricida, Inc. | S Sale | 2019-10-25 | 2019-10-29 | 1,750 | $36.30 | $63.5K | 53,194 | SEC↗ |
| TCDA Tricida, Inc. | S Sale | 2019-10-25 | 2019-10-29 | 1,750 | $36.29 | $63.5K | 53,194 | SEC↗ |
| TCDA Tricida, Inc. | M Exercise | 2019-10-25 | 2019-10-29 | 1,750 | $0.80 | $1.4K | 43,065 | SEC↗ |
| TCDA Tricida, Inc. | M Exercise deriv | 2019-09-26 | 2019-09-30 | 1,400 | — | $0 | 3,500 | SEC↗ |
| TCDA Tricida, Inc. | S Sale | 2019-09-26 | 2019-09-30 | 153 | $32.42 | $5.0K | 54,944 | SEC↗ |
| TCDA Tricida, Inc. | S Sale | 2019-09-26 | 2019-09-30 | 724 | $30.72 | $22.2K | 55,620 | SEC↗ |
| TCDA Tricida, Inc. | S Sale | 2019-09-26 | 2019-09-30 | 573 | $32.12 | $18.4K | 55,047 | SEC↗ |
| TCDA Tricida, Inc. | S Sale | 2019-09-26 | 2019-09-30 | 103 | $32.47 | $3.3K | 54,944 | SEC↗ |
| TCDA Tricida, Inc. | S Sale | 2019-09-26 | 2019-09-30 | 121 | $32.45 | $3.9K | 41,315 | SEC↗ |
| TCDA Tricida, Inc. | S Sale | 2019-09-26 | 2019-09-30 | 694 | $30.66 | $21.3K | 42,021 | SEC↗ |
| TCDA Tricida, Inc. | S Sale | 2019-09-26 | 2019-09-30 | 677 | $30.72 | $20.8K | 55,667 | SEC↗ |
| TCDA Tricida, Inc. | S Sale | 2019-09-26 | 2019-09-30 | 570 | $32.01 | $18.2K | 55,097 | SEC↗ |
| TCDA Tricida, Inc. | M Exercise | 2019-09-26 | 2019-09-30 | 1,400 | $0.80 | $1.1K | 42,715 | SEC↗ |
| TCDA Tricida, Inc. | S Sale | 2019-09-26 | 2019-09-30 | 585 | $32.05 | $18.7K | 41,436 | SEC↗ |
| TCDA Tricida, Inc. | M Exercise deriv | 2019-08-26 | 2019-08-28 | 1,400 | — | $0 | 4,900 | SEC↗ |
| TCDA Tricida, Inc. | M Exercise | 2019-08-26 | 2019-08-28 | 1,400 | $0.80 | $1.1K | 42,715 | SEC↗ |
| TCDA Tricida, Inc. | S Sale | 2019-08-26 | 2019-08-28 | 1,400 | $33.17 | $46.4K | 56,344 | SEC↗ |
| TCDA Tricida, Inc. | S Sale | 2019-08-26 | 2019-08-28 | 1,400 | $33.14 | $46.4K | 56,344 | SEC↗ |
| TCDA Tricida, Inc. | S Sale | 2019-08-26 | 2019-08-28 | 1,400 | $33.18 | $46.5K | 41,315 | SEC↗ |
| TCDA Tricida, Inc. | M Exercise deriv | 2019-07-25 | 2019-07-29 | 1,400 | — | $0 | 6,300 | SEC↗ |
| TCDA Tricida, Inc. | S Sale | 2019-07-25 | 2019-07-29 | 1,400 | $31.62 | $44.3K | 57,744 | SEC↗ |
| TCDA Tricida, Inc. | S Sale | 2019-07-25 | 2019-07-29 | 1,400 | $31.64 | $44.3K | 57,744 | SEC↗ |
| TCDA Tricida, Inc. | S Sale | 2019-07-25 | 2019-07-29 | 1,400 | $31.61 | $44.3K | 41,315 | SEC↗ |
| TCDA Tricida, Inc. | M Exercise | 2019-07-25 | 2019-07-29 | 1,400 | $0.80 | $1.1K | 42,715 | SEC↗ |
| TCDA Tricida, Inc. | M Exercise deriv | 2019-07-05 | 2019-07-09 | 1,100 | — | $0 | 7,700 | SEC↗ |
| TCDA Tricida, Inc. | M Exercise | 2019-07-05 | 2019-07-09 | 1,100 | $0.80 | $880 | 42,415 | SEC↗ |
| TCDA Tricida, Inc. | S Sale | 2019-07-05 | 2019-07-09 | 1,100 | $36.29 | $39.9K | 41,315 | SEC↗ |
| TCDA Tricida, Inc. | S Sale | 2019-07-05 | 2019-07-09 | 1,192 | $36.30 | $43.3K | 59,144 | SEC↗ |
| TCDA Tricida, Inc. | S Sale | 2019-07-05 | 2019-07-09 | 1,200 | $36.30 | $43.6K | 59,144 | SEC↗ |
| TCDA Tricida, Inc. | M Exercise deriv | 2019-07-03 | 2019-07-05 | 3,100 | — | $0 | 8,800 | SEC↗ |
| TCDA Tricida, Inc. | S Sale | 2019-07-03 | 2019-07-05 | 3,008 | $36.89 | $111.0K | 60,336 | SEC↗ |
| TCDA Tricida, Inc. | S Sale | 2019-07-03 | 2019-07-05 | 3,100 | $36.91 | $114.4K | 41,315 | SEC↗ |
| TCDA Tricida, Inc. | M Exercise | 2019-07-03 | 2019-07-05 | 3,100 | $0.80 | $2.5K | 44,415 | SEC↗ |
| TCDA Tricida, Inc. | S Sale | 2019-07-03 | 2019-07-05 | 3,000 | $36.91 | $110.7K | 60,344 | SEC↗ |
| SCPH scPharmaceuticals Inc. | A Award deriv | 2019-06-18 | 2019-06-20 | 6,124 | — | $0 | 6,124 | SEC↗ |
| TCDA Tricida, Inc. | A Award deriv | 2019-05-31 | 2019-06-04 | 7,068 | — | $0 | 7,068 | SEC↗ |
| TCDA Tricida, Inc. | A Award | 2019-05-31 | 2019-06-04 | 1,879 | — | $0 | 41,315 | SEC↗ |
| TCDA Tricida, Inc. | M Exercise deriv | 2019-03-28 | 2019-03-29 | 22,100 | — | $0 | 11,900 | SEC↗ |
| TCDA Tricida, Inc. | S Sale | 2019-03-28 | 2019-03-29 | 22,100 | $34.19 | $755.6K | 39,436 | SEC↗ |
| TCDA Tricida, Inc. | M Exercise | 2019-03-28 | 2019-03-29 | 22,100 | $0.80 | $17.7K | 61,536 | SEC↗ |
| TCDA Tricida, Inc. | S Sale | 2019-03-28 | 2019-03-29 | 22,100 | $34.18 | $755.4K | 63,344 | SEC↗ |
| TCDA Tricida, Inc. | S Sale | 2019-03-28 | 2019-03-29 | 22,100 | $34.19 | $755.6K | 63,344 | SEC↗ |
| TCDA Tricida, Inc. | M Exercise deriv | 2019-03-26 | 2019-03-28 | 4,000 | — | $0 | 34,000 | SEC↗ |
| TCDA Tricida, Inc. | S Sale | 2019-03-26 | 2019-03-28 | 4,000 | $23.84 | $95.4K | 85,444 | SEC↗ |
| TCDA Tricida, Inc. | M Exercise | 2019-03-26 | 2019-03-28 | 4,000 | $0.80 | $3.2K | 43,436 | SEC↗ |
| TCDA Tricida, Inc. | S Sale | 2019-03-26 | 2019-03-28 | 4,000 | $23.80 | $95.2K | 85,444 | SEC↗ |
| TCDA Tricida, Inc. | S Sale | 2019-03-26 | 2019-03-28 | 4,000 | $23.85 | $95.4K | 39,436 | SEC↗ |
| TCDA Tricida, Inc. | M Exercise deriv | 2019-02-25 | 2019-02-27 | 4,000 | — | $0 | 38,000 | SEC↗ |
| TCDA Tricida, Inc. | S Sale | 2019-02-25 | 2019-02-27 | 4,000 | $22.60 | $90.4K | 89,444 | SEC↗ |
| TCDA Tricida, Inc. | S Sale | 2019-02-25 | 2019-02-27 | 4,000 | $22.60 | $90.4K | 39,436 | SEC↗ |
| TCDA Tricida, Inc. | M Exercise | 2019-02-25 | 2019-02-27 | 4,000 | $0.80 | $3.2K | 43,436 | SEC↗ |
| TCDA Tricida, Inc. | S Sale | 2019-02-25 | 2019-02-27 | 4,000 | $22.59 | $90.4K | 89,444 | SEC↗ |
| TCDA Tricida, Inc. | M Exercise deriv | 2019-01-28 | 2019-01-30 | 2,000 | $0.80 | $1.6K | 42,000 | SEC↗ |
| TCDA Tricida, Inc. | S Sale | 2019-01-28 | 2019-01-30 | 2,000 | $20.29 | $40.6K | 39,436 | SEC↗ |
| TCDA Tricida, Inc. | M Exercise | 2019-01-28 | 2019-01-30 | 2,000 | $0.80 | $1.6K | 41,436 | SEC↗ |
| TCDA Tricida, Inc. | S Sale | 2019-01-28 | 2019-01-30 | 2,000 | $20.32 | $40.6K | 93,444 | SEC↗ |
| TCDA Tricida, Inc. | S Sale | 2019-01-28 | 2019-01-30 | 2,000 | $20.33 | $40.7K | 93,444 | SEC↗ |
| TCDA Tricida, Inc. | M Exercise deriv | 2019-01-25 | 2019-01-28 | 2,000 | — | $0 | 44,000 | SEC↗ |
| TCDA Tricida, Inc. | S Sale | 2019-01-25 | 2019-01-28 | 2,000 | $20.85 | $41.7K | 39,436 | SEC↗ |
| TCDA Tricida, Inc. | M Exercise | 2019-01-25 | 2019-01-28 | 2,000 | $0.80 | $1.6K | 41,436 | SEC↗ |
| TCDA Tricida, Inc. | S Sale | 2019-01-25 | 2019-01-28 | 2,000 | $20.86 | $41.7K | 95,444 | SEC↗ |
| TCDA Tricida, Inc. | S Sale | 2019-01-25 | 2019-01-28 | 2,000 | $20.88 | $41.8K | 95,444 | SEC↗ |
| TCDA Tricida, Inc. | M Exercise deriv | 2018-12-27 | 2018-12-31 | 997 | — | $0 | 46,000 | SEC↗ |
| TCDA Tricida, Inc. | S Sale | 2018-12-27 | 2018-12-31 | 997 | $23.63 | $23.6K | 39,436 | SEC↗ |
| TCDA Tricida, Inc. | M Exercise | 2018-12-27 | 2018-12-31 | 997 | $0.80 | $798 | 40,433 | SEC↗ |
| TCDA Tricida, Inc. | S Sale | 2018-12-27 | 2018-12-31 | 700 | $23.78 | $16.6K | 97,444 | SEC↗ |
| TCDA Tricida, Inc. | S Sale | 2018-12-27 | 2018-12-31 | 740 | $23.74 | $17.6K | 97,444 | SEC↗ |
| TCDA Tricida, Inc. | M Exercise deriv | 2018-12-26 | 2018-12-28 | 3,254 | — | $0 | 46,997 | SEC↗ |
| TCDA Tricida, Inc. | S Sale | 2018-12-26 | 2018-12-28 | 3,300 | $24.97 | $82.4K | 98,144 | SEC↗ |
| TCDA Tricida, Inc. | M Exercise | 2018-12-26 | 2018-12-28 | 3,254 | $0.80 | $2.6K | 42,690 | SEC↗ |
| TCDA Tricida, Inc. | S Sale | 2018-12-26 | 2018-12-28 | 3,260 | $24.97 | $81.4K | 98,184 | SEC↗ |
| TCDA Tricida, Inc. | S Sale | 2018-12-26 | 2018-12-28 | 3,254 | $24.97 | $81.3K | 39,436 | SEC↗ |
| TCDA Tricida, Inc. | A Award deriv | 2018-07-02 | 2018-07-02 | 13,147 | — | $0 | 13,147 | SEC↗ |
| TCDA Tricida, Inc. | A Award | 2018-07-02 | 2018-07-02 | 3,632 | — | $0 | 39,436 | SEC↗ |
| SCPH scPharmaceuticals Inc. | A Award deriv | 2018-06-19 | 2018-06-21 | 6,124 | — | $0 | 6,124 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | A Award deriv | 2015-11-24 | 2015-11-27 | 1,750 | — | $0 | 1,750 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | A Award | 2015-11-24 | 2015-11-27 | 650 | — | $0 | 2,816 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2015-11-10 | 2015-11-12 | 1,000 | — | $0 | 5,972 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-11-10 | 2015-11-12 | 1,000 | $198.25 | $198.3K | 2,166 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2015-11-10 | 2015-11-12 | 1,000 | $21.50 | $21.5K | 3,166 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2015-09-09 | 2015-09-11 | 500 | — | $0 | 6,972 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-09-09 | 2015-09-11 | 500 | $198.25 | $99.1K | 2,166 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2015-09-09 | 2015-09-11 | 500 | $21.50 | $10.8K | 2,666 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2015-08-03 | 2015-08-05 | 500 | — | $0 | 7,472 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2015-08-03 | 2015-08-05 | 500 | $21.50 | $10.8K | 2,666 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-08-03 | 2015-08-05 | 500 | $261.17 | $130.6K | 2,166 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2015-06-10 | 2015-06-12 | 391 | — | $0 | 7,972 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2015-06-10 | 2015-06-12 | 391 | $21.50 | $8.4K | 2,557 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-06-10 | 2015-06-12 | 391 | $238.21 | $93.1K | 2,166 | SEC↗ |
| RLYP Relypsa Inc | M Exercise deriv | 2015-05-11 | 2015-05-13 | 5,834 | — | $0 | 69,543 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2015-05-11 | 2015-05-13 | 391 | — | $0 | 8,363 | SEC↗ |
| RLYP Relypsa Inc | S Sale | 2015-05-11 | 2015-05-13 | 5,834 | $36.06 | $210.4K | 2,712 | SEC↗ |
| RLYP Relypsa Inc | M Exercise | 2015-05-11 | 2015-05-13 | 5,834 | $3.96 | $23.1K | 8,546 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-05-11 | 2015-05-13 | 233 | $283.33 | $66.0K | 2,166 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2015-05-11 | 2015-05-13 | 391 | $21.50 | $8.4K | 2,557 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-05-11 | 2015-05-13 | 158 | $272.79 | $43.1K | 2,399 | SEC↗ |
| RLYP Relypsa Inc | M Exercise deriv | 2015-04-10 | 2015-04-13 | 5,832 | — | $0 | 75,377 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2015-04-10 | 2015-04-14 | 391 | — | $0 | 8,754 | SEC↗ |
| RLYP Relypsa Inc | M Exercise | 2015-04-10 | 2015-04-13 | 5,832 | $3.96 | $23.1K | 8,544 | SEC↗ |
| RLYP Relypsa Inc | S Sale | 2015-04-10 | 2015-04-13 | 5,832 | $35.35 | $206.2K | 2,712 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-04-10 | 2015-04-14 | 391 | $272.10 | $106.4K | 2,166 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2015-04-10 | 2015-04-14 | 391 | $21.50 | $8.4K | 2,557 | SEC↗ |
| RLYP Relypsa Inc | M Exercise deriv | 2015-03-10 | 2015-03-12 | 2,503 | — | $0 | 81,209 | SEC↗ |
| RLYP Relypsa Inc | M Exercise deriv | 2015-03-10 | 2015-03-12 | 3,331 | — | $0 | 12,795 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2015-03-10 | 2015-03-12 | 391 | — | $0 | 9,145 | SEC↗ |
| RLYP Relypsa Inc | S Sale | 2015-03-10 | 2015-03-12 | 5,834 | $38.67 | $225.6K | 2,712 | SEC↗ |
| RLYP Relypsa Inc | M Exercise | 2015-03-10 | 2015-03-12 | 2,503 | $3.96 | $9.9K | 8,546 | SEC↗ |
| RLYP Relypsa Inc | M Exercise | 2015-03-10 | 2015-03-12 | 3,331 | $4.65 | $15.5K | 6,043 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-10 | 2015-03-12 | 158 | $263.25 | $41.6K | 2,166 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-10 | 2015-03-12 | 233 | $261.25 | $60.9K | 2,324 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2015-03-10 | 2015-03-12 | 391 | $21.50 | $8.4K | 2,557 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2015-02-24 | 2015-02-26 | 632 | — | $0 | 9,536 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-02-24 | 2015-02-26 | 632 | $222.50 | $140.6K | 2,166 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2015-02-24 | 2015-02-26 | 632 | $21.50 | $13.6K | 2,798 | SEC↗ |
| RLYP Relypsa Inc | M Exercise deriv | 2015-02-10 | 2015-02-10 | 5,834 | — | $0 | 16,126 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2015-02-10 | 2015-02-12 | 233 | — | $0 | 10,168 | SEC↗ |
| RLYP Relypsa Inc | S Sale | 2015-02-10 | 2015-02-10 | 5,734 | $32.10 | $184.1K | 2,812 | SEC↗ |
| RLYP Relypsa Inc | S Sale | 2015-02-10 | 2015-02-10 | 100 | $32.74 | $3.3K | 2,712 | SEC↗ |
| RLYP Relypsa Inc | M Exercise | 2015-02-10 | 2015-02-10 | 5,834 | $4.65 | $27.1K | 8,546 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-02-10 | 2015-02-12 | 233 | $195.52 | $45.6K | 2,166 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2015-02-10 | 2015-02-12 | 233 | $21.50 | $5.0K | 2,399 | SEC↗ |
| RLYP Relypsa Inc | M Exercise deriv | 2015-01-12 | 2015-01-14 | 5,834 | — | $0 | 21,960 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2015-01-12 | 2015-01-14 | 233 | — | $0 | 10,401 | SEC↗ |
| RLYP Relypsa Inc | S Sale | 2015-01-12 | 2015-01-14 | 1,448 | $32.79 | $47.5K | 2,712 | SEC↗ |
| RLYP Relypsa Inc | S Sale | 2015-01-12 | 2015-01-14 | 4,386 | $32.17 | $141.1K | 4,160 | SEC↗ |
| RLYP Relypsa Inc | M Exercise | 2015-01-12 | 2015-01-14 | 5,834 | $4.65 | $27.1K | 8,546 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-01-12 | 2015-01-14 | 233 | $150.01 | $35.0K | 2,166 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2015-01-12 | 2015-01-14 | 233 | $21.50 | $5.0K | 2,399 | SEC↗ |
| RLYP Relypsa Inc | M Exercise deriv | 2014-12-12 | 2014-12-12 | 9,852 | — | $0 | 27,794 | SEC↗ |
| RLYP Relypsa Inc | M Exercise | 2014-12-12 | 2014-12-12 | 9,852 | $4.65 | $45.8K | 12,564 | SEC↗ |
| RLYP Relypsa Inc | S Sale | 2014-12-12 | 2014-12-12 | 9,852 | $32.50 | $320.2K | 2,712 | SEC↗ |
| RLYP Relypsa Inc | M Exercise deriv | 2014-12-11 | 2014-12-12 | 150 | — | $0 | 37,646 | SEC↗ |
| RLYP Relypsa Inc | S Sale | 2014-12-11 | 2014-12-12 | 150 | $32.50 | $4.9K | 2,712 | SEC↗ |
| RLYP Relypsa Inc | M Exercise | 2014-12-11 | 2014-12-12 | 150 | $4.65 | $698 | 2,862 | SEC↗ |
| RLYP Relypsa Inc | M Exercise deriv | 2014-12-10 | 2014-12-12 | 4,167 | — | $0 | 37,796 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2014-12-10 | 2014-12-12 | 233 | — | $0 | 10,634 | SEC↗ |
| RLYP Relypsa Inc | S Sale | 2014-12-10 | 2014-12-12 | 263 | $32.20 | $8.5K | 2,712 | SEC↗ |
| RLYP Relypsa Inc | S Sale | 2014-12-10 | 2014-12-12 | 3,104 | $31.52 | $97.8K | 2,975 | SEC↗ |
| RLYP Relypsa Inc | S Sale | 2014-12-10 | 2014-12-12 | 800 | $30.38 | $24.3K | 6,079 | SEC↗ |
| RLYP Relypsa Inc | M Exercise | 2014-12-10 | 2014-12-12 | 4,167 | $4.65 | $19.4K | 6,879 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-12-10 | 2014-12-12 | 233 | $144.16 | $33.6K | 2,166 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2014-12-10 | 2014-12-12 | 233 | $21.50 | $5.0K | 2,399 | SEC↗ |
| RLYP Relypsa Inc | M Exercise deriv | 2014-11-20 | 2014-11-24 | 3,334 | — | $0 | 41,963 | SEC↗ |
| RLYP Relypsa Inc | S Sale | 2014-11-20 | 2014-11-24 | 3,334 | $22.50 | $75.0K | 2,712 | SEC↗ |
| RLYP Relypsa Inc | M Exercise | 2014-11-20 | 2014-11-24 | 3,334 | $4.65 | $15.5K | 6,046 | SEC↗ |
| RLYP Relypsa Inc | M Exercise deriv | 2014-11-10 | 2014-11-12 | 2,500 | — | $0 | 45,297 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2014-11-10 | 2014-11-12 | 233 | — | $0 | 10,867 | SEC↗ |
| RLYP Relypsa Inc | S Sale | 2014-11-10 | 2014-11-12 | 2,500 | $20.06 | $50.1K | 2,712 | SEC↗ |
| RLYP Relypsa Inc | M Exercise | 2014-11-10 | 2014-11-12 | 2,500 | $4.65 | $11.6K | 5,212 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-11-10 | 2014-11-12 | 233 | $175.95 | $41.0K | 2,166 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2014-11-10 | 2014-11-12 | 233 | $21.50 | $5.0K | 2,399 | SEC↗ |
| RLYP Relypsa Inc | M Exercise deriv | 2014-10-10 | 2014-10-15 | 2,500 | — | $0 | 47,797 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2014-10-10 | 2014-10-15 | 391 | — | $0 | 11,100 | SEC↗ |
| RLYP Relypsa Inc | S Sale | 2014-10-10 | 2014-10-15 | 100 | $19.86 | $2.0K | 2,712 | SEC↗ |
| RLYP Relypsa Inc | S Sale | 2014-10-10 | 2014-10-15 | 2,400 | $19.32 | $46.4K | 2,812 | SEC↗ |
| RLYP Relypsa Inc | M Exercise | 2014-10-10 | 2014-10-15 | 2,500 | $4.65 | $11.6K | 5,212 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-10-10 | 2014-10-15 | 391 | $223.65 | $87.4K | 2,166 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2014-10-10 | 2014-10-15 | 391 | $21.50 | $8.4K | 2,557 | SEC↗ |
| RLYP Relypsa Inc | M Exercise deriv | 2014-09-10 | 2014-09-11 | 4,167 | — | $0 | 50,297 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2014-09-10 | 2014-09-12 | 391 | — | $0 | 11,491 | SEC↗ |
| RLYP Relypsa Inc | M Exercise | 2014-09-10 | 2014-09-11 | 4,167 | $4.65 | $19.4K | 6,879 | SEC↗ |
| RLYP Relypsa Inc | S Sale | 2014-09-10 | 2014-09-11 | 4,167 | $23.00 | $95.8K | 2,712 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2014-09-10 | 2014-09-12 | 391 | $21.50 | $8.4K | 2,557 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-09-10 | 2014-09-12 | 391 | $280.50 | $109.7K | 2,166 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2014-08-12 | 2014-08-15 | 316 | — | $0 | 11,882 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2014-08-12 | 2014-08-15 | 316 | $21.50 | $6.8K | 2,482 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-08-12 | 2014-08-15 | 316 | $345.62 | $109.2K | 2,166 | SEC↗ |
| RLYP Relypsa Inc | M Exercise deriv | 2014-08-11 | 2014-08-12 | 4,167 | — | $0 | 54,464 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2014-08-11 | 2014-08-12 | 391 | — | $0 | 12,198 | SEC↗ |
| RLYP Relypsa Inc | S Sale | 2014-08-11 | 2014-08-12 | 4,167 | $27.73 | $115.6K | 2,712 | SEC↗ |
| RLYP Relypsa Inc | M Exercise | 2014-08-11 | 2014-08-12 | 4,167 | $4.65 | $19.4K | 6,879 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-08-11 | 2014-08-12 | 391 | $239.49 | $93.6K | 2,166 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2014-08-11 | 2014-08-12 | 391 | $21.50 | $8.4K | 2,557 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-08-11 | 2014-08-12 | 1 | $238.28 | $238 | 2,166 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-08-11 | 2014-08-12 | 93 | $238.26 | $22.2K | 2,167 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-08-11 | 2014-08-12 | 6 | $238.25 | $1.4K | 2,260 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-08-11 | 2014-08-12 | 64 | $234.71 | $15.0K | 2,266 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2014-08-09 | 2014-08-12 | 324 | — | $0 | 0 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2014-08-09 | 2014-08-12 | 324 | — | $0 | 2,330 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | A Award deriv | 2014-07-17 | 2014-07-21 | 275 | — | $0 | 275 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | A Award | 2014-07-17 | 2014-07-21 | 226 | — | $0 | 2,006 | SEC↗ |
| RLYP Relypsa Inc | M Exercise deriv | 2014-07-10 | 2014-07-11 | 4,167 | — | $0 | 58,631 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2014-07-10 | 2014-07-11 | 391 | — | $0 | 12,589 | SEC↗ |
| RLYP Relypsa Inc | M Exercise | 2014-07-10 | 2014-07-11 | 4,167 | $4.65 | $19.4K | 6,879 | SEC↗ |
| RLYP Relypsa Inc | S Sale | 2014-07-10 | 2014-07-11 | 4,167 | $23.12 | $96.3K | 2,712 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-07-10 | 2014-07-11 | 233 | $216.88 | $50.5K | 1,938 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2014-07-10 | 2014-07-11 | 391 | $21.50 | $8.4K | 2,171 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-07-10 | 2014-07-11 | 158 | $222.50 | $35.2K | 1,780 | SEC↗ |
| RLYP Relypsa Inc | A Award deriv | 2014-06-19 | 2014-06-23 | 3,828 | — | $0 | 3,828 | SEC↗ |
| RLYP Relypsa Inc | A Award | 2014-06-19 | 2014-06-23 | 2,712 | — | $0 | 2,712 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2014-05-09 | 2014-05-09 | 325 | — | $0 | 324 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2014-05-09 | 2014-05-09 | 325 | — | $0 | 1,942 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-05-09 | 2014-05-09 | 62 | $228.69 | $14.2K | 1,880 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-05-09 | 2014-05-09 | 100 | $232.35 | $23.2K | 1,780 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-05-07 | 2014-05-09 | 100 | $261.42 | $26.1K | 2,182 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-05-07 | 2014-05-09 | 65 | $251.25 | $16.3K | 1,617 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-05-07 | 2014-05-09 | 100 | $254.09 | $25.4K | 2,082 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-05-07 | 2014-05-09 | 100 | $254.00 | $25.4K | 1,982 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-05-07 | 2014-05-09 | 100 | $255.91 | $25.6K | 1,882 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-05-07 | 2014-05-09 | 100 | $252.31 | $25.2K | 1,782 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-05-07 | 2014-05-09 | 100 | $250.46 | $25.0K | 1,682 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-02-10 | 2014-02-11 | 1 | $385.00 | $385 | 2,334 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-02-10 | 2014-02-11 | 52 | $385.04 | $20.0K | 2,282 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-02-10 | 2014-02-11 | 1 | $384.77 | $385 | 2,335 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-02-10 | 2014-02-11 | 7 | $384.33 | $2.7K | 2,336 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-02-10 | 2014-02-11 | 1 | $374.09 | $374 | 2,343 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-02-10 | 2014-02-11 | 100 | $373.34 | $37.3K | 2,344 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2014-02-09 | 2014-02-11 | 324 | — | $0 | 649 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2014-02-09 | 2014-02-11 | 324 | — | $0 | 2,444 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2013-11-11 | 2013-11-12 | 62 | $48.81 | $3.0K | 2,220 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2013-11-11 | 2013-11-12 | 100 | $49.01 | $4.9K | 2,120 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2013-11-09 | 2013-11-12 | 325 | — | $0 | 973 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2013-11-09 | 2013-11-12 | 325 | — | $0 | 2,282 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2013-10-01 | 2013-10-03 | 100 | $74.25 | $7.4K | 2,228 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2013-10-01 | 2013-10-03 | 100 | $73.57 | $7.4K | 2,328 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2013-10-01 | 2013-10-03 | 100 | $72.64 | $7.3K | 2,428 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2013-10-01 | 2013-10-03 | 100 | $74.77 | $7.5K | 2,128 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2013-10-01 | 2013-10-03 | 100 | $74.89 | $7.5K | 2,028 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2013-10-01 | 2013-10-03 | 71 | $75.00 | $5.3K | 1,957 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2013-10-01 | 2013-10-03 | 100 | $69.26 | $6.9K | 2,528 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2013-08-09 | 2013-08-13 | 325 | — | $0 | 1,298 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2013-08-09 | 2013-08-13 | 325 | — | $0 | 2,628 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2013-05-09 | 2013-05-09 | 324 | — | $0 | 1,623 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2013-05-09 | 2013-05-09 | 324 | — | $0 | 973 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | A Award deriv | 2013-05-07 | 2013-05-09 | 1,980 | — | $0 | 1,980 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | A Award | 2013-05-07 | 2013-05-09 | 1,330 | — | $0 | 2,303 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2013-04-09 | 2013-04-11 | 649 | — | $0 | 1,947 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2013-04-09 | 2013-04-11 | 649 | — | $0 | 649 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | A Award deriv | 2012-11-16 | 2012-11-20 | 12,980 | — | $0 | 12,980 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | A Award deriv | 2012-11-16 | 2012-11-20 | 2,596 | — | $0 | 2,596 | SEC↗ |